Emmac

London, United Kingdom Founded: 2018 • Age: 8 yrs Acquired By Curaleaf
Medical cannabis products are produced and supplied by Emmac.
Annual revenue $6.8M Latest available
Total funding $69.1M 6 rounds
Employees 187 Tracked headcount
Investors 4 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About Emmac

Emmac is a company based in London (United Kingdom) founded in 2018 was acquired by Curaleaf in March 2021. Emmac has raised $69.14 million across 6 funding rounds from investors including Curaleaf, Fastforward Innovations and Measure 8 Ventures Management. The company has 187 employees as of January 31, 2020. Emmac has completed 5 acquisitions, including Green Leaf Company, Medalchemy and Rokshaw. Emmac operates in a competitive market with competitors including Ignite, Totally Natural Solutions, Taylor Mammon, HempyBuds and CBD Wizard, among others.

  • Headquarter London, United Kingdom
  • Employees 187 as on 31 Jan, 2020
  • Sectors
    Healthcare
    Agriculture Retail
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Emmac Life Sciences Limited
Operational Areas
Healthcare → Health Technology & Digital Health Unlock Sub-Sector Unlock Segment
Agriculture → Agricultural Technology & Innovation Unlock Sub-Sector Unlock Segment
Retail → E-Commerce Platforms & Marketplaces Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $6.8 M (USD)
    0
    as on Dec 31, 2019
  • Net Profit
    -$13.65 M (USD)
    -1928
    as on Dec 31, 2019
  • EBITDA
    Not available
  • Total Equity Funding
    $69.14 M (USD)

    in 6 rounds

  • Latest Funding Round
    $20.06 M (USD), Series D

    Dec 16, 2020

  • Investors
    Curaleaf

    & 3 more

  • Employee Count
    187

    as on Jan 31, 2020

  • Investments & Acquisitions
  • Acquired by
    Curaleaf

    (Mar 09, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Emmac

Emmac has successfully raised a total of $69.14M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $20.06 million completed in December 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Emmac

Emmac has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Curaleaf, Fastforward Innovations and Measure 8 Ventures Management.

All
Venture Fund
Investor Description Founded Year Domain Location
-
Locked Locked Locked
Investments are focused on the emerging global cannabis industry.
Locked Locked Locked
Tech & life Science focused early stage VC firm investing in North America & Europe
Locked Locked Locked
Premium access

Investor details for Emmac

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Emmac

Emmac has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Green Leaf Company, Medalchemy and Rokshaw.

Investments
Premium access

Investment portfolio details for Emmac

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Provider of cannabis hemp oil, hemp protein, and shelled seeds services
Locked Locked 2017 Locked
Specialty medicines are manufactured and supplied across the UK.
Locked Locked 2012 Locked
Fine chemicals, APIs, and intermediates are developed and manufactured.
Locked Locked 2002 Locked
Premium access

Complete acquisition details for Emmac

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Emmac

Premium access

Detailed financials for Emmac

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Emmac Comparisons

Emmac Primary company
Description
Medical cannabis products are produced and supplied by Emmac...
Location
London, United Kingdom
Founded Year
2018
Annual Revenue
$6.8 M (USD)
Net Profit
-$13.65 M (USD)
EBITDA
Not available
Employees
187
As of 2020
Premium access

Peer comparison for Emmac

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Emmac

Emmac operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ignite, Totally Natural Solutions, Taylor Mammon, HempyBuds and CBD Wizard, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Online marketplace platform for cannabis products is provided.
Locked Locked Locked
Produces natural hop extracts to enhance beer flavor, reduce waste, and improve brewing processes.
Locked Locked Locked
Cannabis-infused products are developed via CO2 extraction methods.
Locked Locked Locked
Manages an e-commerce store for cannabis buds and related products.
Locked Locked Locked
Online and in-store retailer of CBD products including oils and edibles.
Premium access

Detailed competitors of Emmac

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Emmac

Premium access

Complete news archive for Emmac

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Emmac

Emmac was founded in 2018 and raised its 1st funding round 1 year after it was founded.

Emmac is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

Matthew Darin Darin is the current CEO of Emmac.

Emmac is a funded company, having raised a total of $69.14M across 6 funding rounds to date.

As of Jan 31, 2020, the latest employee count at Emmac is 187.

Annual revenue of Emmac is $6.8M as on Dec 31, 2019.

Emmac was founded in 2018 and is based in London, United Kingdom. Operations focus on the medical cannabis sector, encompassing research and development, cultivation, production, and distribution of products such as CBD items, cannabinoids, and hemp extracts. Cannabis-derived products are supplied to the cosmetic, food, and nutraceutical industries.

Emmac's top competitors include Ignite, Taylor Mammon and Totally Natural Solutions.

Emmac has made 5 acquisitions, including Green Leaf Company, Medalchemy, and Rokshaw.

Emmac has 4 investors. Key investors include Curaleaf, Fastforward Innovations, Measure 8 Ventures Management, and Altitude Investment Management.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available